High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients., HONDA Hirokazu;MICHIHATA Tetsuo;SHISHIDO Kanji;TAKAHASHI Keiko;TAKAHASHI Go;HOSAKA Nozomu;IKEDA Misa;SANADA Daisuke;SHIBATA Takanori, PloS One, 12(5):e0176984, 2017年05月, 原著, 査読あり
Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis., HONDA Hirokazu;HIRANO Tsutomu;UEDA Masashi;KOJIMA Shiho;MASHIBA Shinichi;HAYASE Yasuyuki;MICHIHATA Tetsuo;SHISHIDO Kanji;TAKAHASHI Keiko;HOSAKA Nozomu;IKEDA Misa;SANADA Daisuke;SHIBATA Takanori, PloS One, 12(5):e0177980, 2017年05月, 原著, 査読あり
Cardiac effect of vitamin D receptor modulators in uremic rats., MIZOBUCHI Masahide;OGATA Hiroaki;YAMAZAKI-NAKAZAWA Ai;HOSAKA Nozomu;KONDO Fumiko;KOIWA Fumihiko;KINUGASA Eriko;SHIBATA Takanori, J Steroid Biochem Mol Biol, 163:20 - 27, 2016年10月, 原著, 査読あり
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients, HONDA Hirokazu;HOSAKA Nozomu;AOSHIMA Yumie;HIRAI Yuki;MICHIHATA Tetsuo;AKIZAWA Tadao, Clin Exp Hypertens, 34(1):17 - 23, 2011年12月, 原著, 査読あり
腎性貧血治療と健康関連QOL, 長谷川 毅;保坂 望, Prog Med, 31(2):421 - 427, 2011年02月
A case of tuberculous peritonitis in a hemodialysis patient with high serum soluble interleukin-2 receptor and CA-125 levels., KUNO Yoshihiro;IYODA Masayuki;AOSHIMA Yumie;HOSAKA Nozomu;SANADA Daisuke;HIRAI Yuki;SHIBATA Takanori;AKIZAWA Tadao, Intern Med, 49(16):1783 - 1786, 2010年08月, 原著, 査読あり
Oxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patients, HONDA Hirokazu;UEDA Masashi;KOJIMA Shiho;MASHIBA Shinichi;SUZUKI Hiroki;HOSAKA Nozomu;HIRAI Yuki;NAKAMURA Mari;NAGAI Hisako;KATO Noriyuki;MUKAI Masanori;WATANABE Makoto;TAKAHASHI Keiko;SHISHIDO Kanji;AKIZAWA Tadao, Clin J Am Soc Nephrol, 5(6):1021 - 1028, 2010年06月, 原著, 査読あり
Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients, ASHIKAGA Eijin;HONDA Hirokazu;SUZUKI Hiroki;HOSAKA Nozomu;HIRAI Yuki;SANADA Daisuke;NAKAMURA Mari;NAGAI Hisako;MATSUMOTO Kei;KATO Norayuki;MUKAI Masanori;WATANABE Makoto;TAKAHASHI Keiko;SHISHIDO Kanji;AKIZAWA Tadao, Ther Apher Dial., 14(3):315 - 322, 2010年06月, 原著, 査読あり